English
中文
HOME
ABOUT US
COMPANY PROFILE
ENTERPRISE VISION
JOIN US
PRODUCTS
API
ADVANCED INTERMEDIATES
PEPTIDES
FINE CHEMICALS
OTHERS
SERVICE
DMF/CMC/ SMF PREPARATION
PRE-AUDIT/AUDIT INTERPRETATION
PHARMACEUTICAL DOCUMENT TRANSLATION
eCTD DMF SUBMISSION
MOST RECOMMENDED
QUALITY & COMPLIANCE
NEWS
COMPANY NEWS
INDUSTRY NEWS
STATEMENT!!!
CONTACT US
Home >
NEWS
NEWS
COMPANY NEWS
INDUSTRY NEWS
STATEMENT!!!
Molnupiravir FDA Approval Status
Molnupiravir (EIDD-2801/MK-4482) is an investigational, orally bioavailable form of a potent ribonucleoside analog in development for the treatment of COVID-19.1.Molnupiravir works as an antiviral agent by inhibiting the replication of the SARS-CoV-2 virus, th..
2021-10-25
COVID-19 tracker: CureVac sees hope for vaccine despite trial flop; AZ jab highly protective against death in older adults
CureVac said its vaccine, only 48% effective in late-stage clinical trials, could still pose a "strong public health value."Two doses of AstraZeneca's vaccine prevent roughly 94% of deaths in older people, according to Public Health England.The w..
2021-07-02
COVID-19 tracker: Azar pegs 6.4M Pfizer doses for mid-December delivery; GAVI welcomes AZ shot data
The U.S. expects to distribute 6.4 million doses of Pfizer and BioNTech's shot by mid-December, should the vaccine pass the FDA's bar, Department of Health and Human Services secretary Alex Azar said. Meanwhile, the World Health Organization's vacc..
2020-11-26
Pfizer urged to hold off on coronavirus vaccine until late November: report
Pfizer CEO Albert Bourla and his vaccine partner BioNTech have said the companies expect phase 3 data by the end of October—and that an FDA application could soon follow. But more than 60 researchers and bioethicists urged the partners to wait for mor..
2020-09-29
Judge wipes out Biogen's Tecfidera patent protections in suit against Mylan
In the high-stakes patent fight between Biogen and Mylan over Tecfidera’s main remaining patent, Mylan has scored a major win in federal court.U.S. District Judge Irene Keeley said Mylan “demonstrated by clear and convincing evidence” that certain claims ..
2020-06-19
Takeda, debt in mind, offloads 18 drugs in Asia Pacific to Celltrion for $278M
Takeda has earmarked another chunk of business for divestment to help it pay down debt.The Japanese pharma is offloading 18 over-the-counter and prescription drugs marketed in the Asia-Pacific region to South Korea’s Celltrion for $278 million, it said on T..
2020-06-12
First
Previous
current 1/6 page
total 33 records
per page 6 Article
1
2
3
Next
End
PRODUCTS
API
ADVANCED INTERMEDIATES
PEPTIDES
FINE CHEMICALS
OTHERS
SERVICE
DMF/CMC/ SMF PREPARATION
PRE-AUDIT/AUDIT INTERPRETATION
PHARMACEUTICAL DOCUMENT TRANSLATION
eCTD DMF SUBMISSION
NEWS
COMPANY NEWS
INDUSTRY NEWS
STATEMENT!!!
Copyright Copyright (C) 2015-2035 Senova Technology Co. Ltd.
Address: 510# in Building 8 of North Area, Dayuan Industry Park, Xili, Nanshan District of Shenzhen,China 518055 Tel:
+86-0755-8670 3119
QQ: 530953397 Email:
info@senovatech.com